283
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study

&
Pages 1455-1469 | Published online: 05 Dec 2013

References

  • Hoffman A Pharmacodynamic aspects of sustained release preparations Adv Drug Deliv Rev 1998 33 185 199 10837659
  • Klausner EA Lavy E Friedman M Hoffman A Expandable gastroretentive dosage forms J Control Release 2003 90 143 162 12810298
  • Qassim SMAinventor Tabuk Pharmaceutical Manufacturing Co, assignee Pharmaceutical compositions of ciprofloxacin European patent EP1880722B1 3 17 2010
  • Hoffman A Stepensky D Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy Crit Rev Ther Drug Carrier Syst 1999 16 571 639 10677802
  • Dhaliwal S Jain S Singh HP Tiwary AK Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation AAPS J 2008 10 322 330 18523891
  • Riner JL Byford RL Stratton LG Hair JA Influence of density and location on degradation of sustained-release boluses given to cattle Am J Vet Res 1982 43 11 2028 2030 7181203
  • Reddy LH Murthy RS Floating dosage systems in drug delivery Crit Rev Ther Drug Carrier Syst 2002 19 6 553 585 12822735
  • Klausner EA Eyal S Lavy E Friedman M Hoffman A Novel levodopa gastroretentive dosage form: in vivo evaluation in dogs J Control Release 2003 88 1 117 126 12586509
  • Kedzierewicz F Thouvenot P Lemut J Etienne A Hoffman M Maincent P Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy J Control Release 1999 58 2 195 205 10053192
  • Chen J Blevins WE Park H Park K Gastric retention properties of superporous hydrogel composites J Control Release 2000 64 1–3 39 51 10640644
  • Akiyama Y Nagahara N Nara E Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites J Pharm Pharmacol 1998 50 2 159 166 9530983
  • Groning R Berntgen M Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule Pharmazie 1996 51 5 328 331 8710954
  • Chiou WL Barve A Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats Pharm Res 1998 15 11 1792 1795 9834005
  • Lewis LD Fowle ASE Bittiner SB Bye A Isaacs PET Human gastrointestinal absorption of acyclovir from tablet duodenal infusion and sipped solution Br J Clin Pharmacol 1986 21 4 459 462 3707815
  • Gröning R Berntgen M Georgarakis M Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit Eur J Pharm Biopharm 1998 46 3 285 291 9885300
  • O’Brien JJ Campoli-Richards DM Acyclovir: an updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy Drugs 1989 37 3 233 309 2653790
  • Fuertes I Miranda A Millán M Caraballo I Estimation of the percolation thersholds in acyclovir hydrophilic matrix tablets Eur J Pharm Biopharm 2006 64 3 336 342 16876392
  • Garg R Gupta GD Preparation and evaluation of gastroretentive floating tablets of acyclovir Curr Drug Deliv 2009 6 5 437 443 19751200
  • Sankar R Jain SK Determination of target in vitro drug release profile for extended release formulation of acyclovir through pharmacokinetic simulations Anti-Infect Agents 2013 11 2 204 211
  • United States Pharmacopeia and National Formulary (USP 36-NF 31) Acyclovir tablets Rockville, MD The United States Pharmacopeial Convention 2013 2342 2343
  • Indian Pharmacopoeia Uniformity of weight of single dose preparations Ghaziabad Indian Pharmacopoeia Commission 2010 1 192
  • Indian Pharmacopoeia Friability of uncoated tablets Ghaziabad Indian Pharmacopoeia Commission 2010 1 193
  • Moore JW Flanner HH Mathematical comparison of dissolution profiles Pharm Tech 1996 20 64 74
  • Costa P Lobo JMS Modeling and comparison of dissolution profiles Eur J Pharm Sci 2001 13 2 123 133 11297896
  • Siepmann J Peppas NA Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) Adv Drug Deliv Rev 2001 48 2–3 139 157 11369079
  • Al-Taani BM Tashtoush BM Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium AAPS PharmSciTech 2003 4 3 E43 14621975
  • Ravindran VK Vasa S Subadhra S Banji D Banji O Rao YM Comparative study of mucoadhesive polymers carbopol 974P and sodium carboxymethyl cellulose for single unit dosage of imatinib mesylate Malaysian J Pharm Sci 2012 10 1 61 77
  • Badhan AC Mashru RC Shah PP Thakkar AR Dobaria NB Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection AAPS PharmSciTech 2009 10 2 459 467 19381827
  • Baskar GV Narayanan N Gaikwad R Abdul S Formulation and evaluation of gastro-retentive floating multi-particulate system of metoprolol tartarate Trop J Pharm Res 2010 9 2 181 186
  • Nagarwal RC Ridhurkar DN Pandit JK In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet AAPS PharmSciTech 2010 11 1 294 303 20182827
  • Thakar K Joshi G Sawant KK Bioavailability enhancement of baclofen by gastroretentive floating formulation: statistical optimization, in vitro and in vivo pharmacokinetic studies Drug Dev Ind Pharm 2013 39 6 880 888 22901056
  • Chary RBR Vani G Rao YM In vitro and in vivo adhesion testing of mucoadhesive testing of mucoadhesive drug delivery systems Drug Dev Ind Pharm 1999 25 5 685 690 10219540
  • United States Pharmacopeia and National Formulary (USP 36-NF 31) Acyclovir Rockville, MD The United States Pharmacopeial Convention 2013 2338 2339
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use [webpage on the Internet] ICH Q1C. Stability testing for new dosage forms 1997 Available from: http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html Accessed January 15, 2013
  • Colorcon Polyox™, Water-Soluble Polymers for Pharmaceutical Applications Harleysville (PA) BPSI Holdings, LLC 2009 Available from: http://www.colorcon.com/literature/marketing/mr/Extended%20Release/POLYOX/English/Colorcon_PIB_POLYOX.pdf Accessed April 12, 2013
  • Lubrizol Pharmaceutical Polymers for Oral Solid Dosage Forms Cleve-land (OH) Lubrizol 2011 Available from: http://www.lubrizol.com/Pharmaceutical-Ingredients/Documents/Brochures/Pharmaceutical-Polymers-for-Oral-Solid-Dosage-Forms.pdf Accessed April 12, 2013
  • FMC Corporation Alginates for Pharmaceutical and Medical Applications: Performance Enhancing Products Philadelphia (PA) FMC Corporation 2008 Available from: http://www.fmcbio-polymer.com/Portals/ISP/Content/Docs/Alginates%20for%20Pharmaceutical%20and%20Medical%20Applications.pdf Accessed April 12, 2013
  • Chen JL Cyr GN Compositions producing adhesion through hydration Manly RS Adhesion in Biological Systems New York Academic Press 1970 163 181
  • Duchêne D Ponchel G Principle and investigation of the bioadhesion mechanism of solid dosage forms Biomaterials 1992 13 10 709 715 1420717
  • Park H Robinson JR Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion J Control Release 1985 2 47 57
  • Shahi S Sonawane A Vanamore S Zadbuke N Formulation and in vitro characterization of acyclovir floating matrix tablets: a factorial design study J Applied Pharm Sci 2013 3 5 65 74
  • Wells JI Aulton ME Preformulation Aulton ME Pharmaceutics: The Science of Dosage Form Design London Churchill Livingstone 1988 247 248
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use [webpage on the Internet] ICH Q3C(R5). Impurities: guideline for residual solvents 2011 Available from: http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html Accessed April 12, 2013
  • Gu JM Robinson JR Leung SH Binding of acrylic polymers to mucin/epithelial surfaces: structure-property relationships Crit Rev Ther Drug Carrier Syst 1988 5 1 21 67 3293807
  • Shaikh R Raj Singh TR Garland MJ Woolfson AD Donnelly RF Mucoadhesive drug delivery systems J Pharm Bioallied Sci 2011 3 1 89 100 21430958
  • Roldo M Hornof M Coliceti P Bernkop-Schnürch A Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation Eur J Pharm Biopharm 2004 57 1 115 121 14729087
  • Streubel A Siepmann J Bodmeier R Drug delivery to the upper small intestine window using gastroretentive technologies Curr Opin Phar-macol 2006 6 5 501 508
  • Middleton DL Leung SS Robinson JR Ocular bioadhesive delivery systems Lenaerts V Gurny R Bioadhesive Drug Delivery Systems Boca Raton (FL) CRC Press Inc 1990 179 202